Assessment of Nasal-Brain-Targeting Efficiency of New Developed Mucoadhesive Emulsomes Encapsulating an Anti-Migraine Drug for Effective Treatment of One of the Major Psychiatric Disorders Symptoms

• Main Authors: Hadel A. Abo El-Enin (Author), Rasha E. Mostafa (Author), Marwa F. Ahmed (Author), Ibrahim A. Naguib (Author), Mohamed A. Abdelgawad (Author), Mohammed M. Ghoneim (Author), Ebtsam M. Abdou (Author)
• Format: Book
• Published: MDPI AG, 2022-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Migraine is one of the major symptoms of many psychiatric and mental disorders like depression and anxiety. Eletriptan Hydrobromide (EH) is a well-tolerated drug in migraine treatment, but suffers from low oral bioavailability and low brain targeting after oral delivery. New nasal mucoadhesive EH-em...